Published in Blood Weekly, January 13th, 2000
Chiron's combination HIV/HCV test, developed and manufactured by Gen-Probe Incorporated, is expected to be fully implemented in Australia by mid-2000. The advanced screening test, which incorporates sophisticated new technology, will be used to routinely screen the Australian blood supply, approximately 1 million blood donations per year.
"The ARCBS's adoption of NAT technology is another step towards...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.